Potrzebujesz pomocy eksperta ds. przetargów? Zobacz naszą usługę przygotowania przetargów
Przetargi

Procurement of Vaccines

Zamknięty

Termin składania ofert minął

Termin składania ofert w tym przetargu minął i nie przyjmujemy już zgłoszeń. Poniższe informacje zostały zachowane w celach informacyjnych.

Przeglądaj Aktywne Przetargi
Termin składania ofert
Przeterminowany
10 lutego 2026
Szczegóły umowy
Kategoria
Dostawy
Numer Referencyjny
162456
Wartość
€0
Lokalizacja
Latvia, Łotwa
Opublikowano
20 stycznia 2026
Kod CPV
Harmonogram Projektu

Ogłoszenie przetargu

20 stycznia 2026

Termin składania pytań

3 lutego 2026

Termin składania ofert

10 lutego 2026

Otwarcie ofert

10 lutego 2026

Prawdopodobieństwo wygranejPRO
🔒
Uaktualnij do Professional
Zobacz szacowane prawdopodobieństwo wygranej na podstawie danych historycznych.
Uaktualnij do wersji profesjonalnej →
Analityka zamawiającegoPRO
🔒
Odblokuj analitykę zamawiającego
Zobacz wzorce wydatków, preferowane procedury i więcej.
Uaktualnij do wersji profesjonalnej →
Analiza sektoraPRO
🔒
Odblokuj analizę sektora
Zobacz średnie ceny zwycięskie, poziomy konkurencji i trendy rynkowe.
Uaktualnij do wersji profesjonalnej →
Budżet
€0
Czas trwania
24 miesiące
Lokalizacja
Latvia
Typ
Dostawy
61
Ocena Jakości/100
Dobra
Benchmark rynkowy
Śr. cena wygrywająca
€36,535
Śr. liczba ofert
2.1
Konkurencja
Niska
Zwycięzcy MŚP
100%
23,680 przeanalizowanych zamówień

Oryginalny Opis Przetargu

Procurement of Vaccines

Uruchom analizę ryzyka

Zidentyfikuj potencjalne ryzyka, niespójności i sygnały ostrzegawcze we wszystkich dokumentach przetargowych. Uzyskaj szczegółowy raport ryzyka z poziomami dotkliwości i zaleceniami dotyczącymi ich ograniczania.

Zaloguj się

Strategia wygrywania

Uzyskaj strategię wygrywania opartą na sztucznej inteligencji, dopasowaną do tego przetargu. Obejmuje wskaźnik prawdopodobieństwa wygranej, kluczowe szanse i wyzwania, zalecane obszary oferty, analizę pozycji konkurencyjnej oraz praktyczne rekomendacje maksymalizujące Twoje szanse.

Zaloguj się

Konkurenci

Ulepsz plan, aby zobaczyć, które firmy prawdopodobnie złożą ofertę w tym przetargu, na podstawie historycznych danych zamówień publicznych.

Zaloguj się

Wymagania i Kwalifikacje

17 wymagań w 5 kategoriach

Składanie (5)
Obowiązkowe (3)
Zgodność (3)
Techniczne (3)
Finansowe (3)
SUBMISSION REQUIREMENTS5
--Bidders must submit their offer by the deadline: 2026-02-10T10:00:00.
--Bidders must submit the completed application form.
--Bidders must submit the certification form confirming an independently developed offer and declaring any permitted communications.
MANDATORY EXCLUSION GROUNDS3
--Bidders must certify that their offer was developed independently without collusion with competitors.
--Bidders must declare compliance with all tender terms and conditions.
--Bidders must meet all specified exclusion criteria outlined in the tender documents.
ELIGIBILITY REQUIREMENTS3
--Bidders must submit an application form affirming compliance with tender terms and other required declarations.
--Bidders must meet all specified selection criteria outlined in the tender documents.
--Bidders must provide all necessary licenses as required.
TECHNICAL CAPABILITY REQUIREMENTS3
--Bidders must submit a technical proposal detailing how the offered vaccines meet the specified quality requirements.
--Bidders must provide manufacturer information for each vaccine offered.
--Bidders must ensure the offered vaccines comply with the detailed procurement requirements for each specific part of the tender (e.g., anti-tick, Hepatitis A/B, Pneumococcal, HPV, Rotavirus, Chickenpox vaccines).
FINANCIAL REQUIREMENTS3
--Bidders must submit a financial proposal detailing unit prices and total sums for the offered vaccines.
--Bidders must commit to the pricing provided in their offer.
--Offers will be evaluated based on the lowest price, excluding VAT.

Podgląd wymagań

Zarejestruj się, aby zobaczyć pełne wymagania i analizę

Dokumenty

17 dokumentów dostępnych z podsumowaniami AI

Iepirkuma priekšmeta 10.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_10_20260120112229.pdf -- 97.8 KB

This document contains the requirements for Part 10 (Hepatitis A vaccine for adults) of a vaccine procurement, outlining exclusion and selection criteria, technical and financial offer requirements, and the evaluation criteria based on the lowest price without VAT.

Iepirkuma priekšmeta 11.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_11_20260120112229.pdf -- 97.8 KB

This document outlines the specific requirements for Part 11 (Hepatitis A vaccine for children) of the 'Vaccine Procurement' tender, detailing exclusion and selection criteria, technical and financial proposal requirements, and evaluation criteria for bidders.

Iepirkuma priekšmeta 1.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_1_20260120112228.pdf -- 97.8 KB

This document contains detailed procurement requirements for Part 1 (anti-tick vaccine for adults), outlining exclusion and selection criteria, technical and financial proposal specifications, mandatory submission documents, and evaluation criteria based on the lowest price.

Iepirkuma priekšmeta 12.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_12_20260120112229.pdf -- 97.9 KB

This document outlines the requirements for Part 12 (A+B hepatitis vaccine for adults) of a vaccine procurement tender, detailing exclusion and selection criteria, technical and financial proposal requirements, and evaluation criteria based on the lowest price without VAT.

Iepirkuma priekšmeta 2.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_2_20260120112228.pdf -- 97.8 KB

This document contains the specific requirements and evaluation criteria for Part 2 (anti-tick vaccine for children) of a vaccine procurement tender by Rīgas veselības centrs, detailing the application, declarations, licenses, technical and financial proposals, and other necessary documents bidders must submit.

Iepirkuma priekšmeta 3.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_3_20260120112228.pdf -- 97.8 KB

This document details the mandatory requirements for bidders, including exclusion and selection criteria, technical and financial proposal specifications, and evaluation criteria for the procurement of pneumococcal vaccines for adults.

Iepirkuma priekšmeta 4.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_4_20260120112228.pdf -- 97.8 KB

This document outlines the requirements for Part 4 (Pneumococcal infection vaccines) of the "Rīgas veselības centrs" SIA procurement, detailing exclusion and selection criteria, technical and financial proposal requirements, and evaluation criteria based on the lowest price.

Iepirkuma priekšmeta 5.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_5_20260120112228.pdf -- 97.8 KB

This document contains the detailed procurement requirements for Part 5 (Human papillomavirus vaccine) of the vaccine acquisition, outlining exclusion and selection criteria, technical and financial offer requirements, and the lowest price evaluation method.

Iepirkuma priekšmeta 6.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_6_20260120112228.pdf -- 98.1 KB

This document contains detailed requirements for submitting an offer for the procurement of rotavirus vaccines (Part 6), including exclusion conditions, selection criteria, technical and financial proposal specifications, and evaluation criteria based on the lowest price without VAT.

Iepirkuma priekšmeta 7.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_7_20260120112229.pdf -- 97.9 KB

This document contains the procurement requirements for Part 7 (Chickenpox vaccine) of the vaccine acquisition tender, outlining mandatory submission documents, technical and financial offer specifications, and evaluation criteria based on the lowest price without VAT.

Iepirkuma priekšmeta 8.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_8_20260120112229.pdf -- 97.8 KB

This document details the requirements for Part 8 of a vaccine procurement tender, including exclusion and selection criteria, technical and financial proposal specifications, and evaluation criteria based on the lowest price.

Iepirkuma priekšmeta 9.daļas prasības, 1.versijaPDF
162456_PD.ANY_1_1_9_20260120112229.pdf -- 98.1 KB

This document outlines the specific requirements for Part 9 (Hepatitis B vaccine for adults) of a vaccine procurement tender, detailing exclusion and selection criteria, technical and financial offer requirements, and evaluation criteria based on the lowest price without VAT.

PieteikumsDOC
1.pielikums_pieteikums_1.docx -- 28.4 KB

This document contains an application form for bidders to participate in an open competition for vaccine procurement, requiring declarations of compliance with tender terms, pricing commitments, and various other affirmations.

Apliecinājums par neatkarīgi izstrādātu piedāvājumuDOC
2.pielikums_apliecinajums_par_neatkarigi_izst... -- 24.3 KB

This document contains a certification form for bidders to confirm that their offer was developed independently without collusion with competitors, and to declare any permitted communications.

Tehniskais - finanšu piedāvājumsXLS
3.pielikums_specifikacija_2.xls -- 46.5 KB

This document contains a technical and financial offer template for the procurement of various vaccines, detailing quality requirements, estimated quantities, and fields for bidders to provide manufacturer information, unit prices, and total sums.

Līguma projektsDOC
4.pielikums_ligums.doc -- 101.5 KB

This document contains a draft contract for the procurement of vaccines for the Riga Health Center, outlining the terms for supply, payment, quality, and responsibilities between the client and the supplier.

NolikumsDOC
nolikums_vakcinas_2026.doc -- 237.0 KB

This document contains the regulations for an open competition organized by SIA “Rīgas veselības centrs” for the procurement of vaccines, detailing general information, submission requirements, and terms for bidders.

Podgląd dokumentów

Zarejestruj się, aby zobaczyć podsumowania i analizę dokumentów

61
Dobra

Ocena Jakości Przetargu

This tender for vaccine procurement presents a detailed structure with clear requirements and an open procedure. However, it is significantly undermined by an unrealistic estimated value of 0.01 EUR and reported restricted document access, raising serious concerns about fairness and practical execution.

Szczegółowy Wynik

Zgodność z przepisami75/100

The tender generally complies with legal requirements, featuring a clear open procedure, reasonable submission period, and correct CPV codes. No disputes are reported. However, the 'Restricted document access' flag is a significant concern, potentially hindering transparency and equal treatment, thus lowering the score.

•Restricted document access
Przejrzystość80/100

The tender description is clear, and AI-extracted requirements are well-categorized and detailed. Evaluation criteria (lowest price) are specified, and performance conditions are clearly referenced to specific documents. The overall structure appears well-documented.

Kompletność70/100

All basic information, financial details (though problematic), timeline, and location are provided. A comprehensive list of 18 documents with summaries is available. However, the 'Restricted document access' flag, if true, compromises the practical completeness for bidders, and the unrealistic estimated value makes the financial aspect incomplete in a practical sense.

•Restricted document access
•Unrealistic estimated value (0.01 EUR)
Uczciwość30/100

Fairness is severely impacted by the 'Estimated Value: 0.01 EUR', which is highly unrealistic for vaccine procurement and misleading to potential bidders. Coupled with the 'Restricted document access' flag, these issues fundamentally undermine transparency and equal opportunity. While evaluation criteria are objective, these critical flaws lead to a low score.

•Unrealistic estimated value (0.01 EUR)
•Restricted document access
Praktyczność65/100

The tender lists 'E-Procurement' and specifies a contract duration. However, the 0.01 EUR estimated value makes financial planning and bid preparation highly impractical. The reported 'Restricted document access' also presents a significant practical barrier for bidders. The contradiction regarding e-submission adds confusion.

•Unrealistic estimated value (0.01 EUR)
•Restricted document access
Spójność danych50/100

While most key fields are populated and dates are logical, the 'Estimated Value: 0.01 EUR' is a glaring inconsistency for vaccine procurement. Other contradictions, such as 'E-Procurement' being listed but 'No e-submission' flagged, and 'Restricted document access' despite 18 document summaries, indicate data consistency issues.

•Unrealistic estimated value (0.01 EUR)
•Contradiction regarding e-submission
Zrównoważony rozwój20/100

The tender does not include any explicit green procurement, social aspects, or innovation focus. It is also not indicated as EU funded, which often correlates with higher sustainability standards.

•No green procurement criteria
•No social criteria

Mocne strony

Clear procedure type (open competition) and well-defined requirements.
Detailed breakdown into 12 parts with specific technical specifications.
Objective evaluation criteria (lowest price) and reasonable submission deadline.
Comprehensive list of required submission documents and forms.
E-Procurement characteristic indicates modern procurement practices.

Wątpliwości

Unrealistic estimated value (0.01 EUR) for vaccine procurement, severely impacting fairness and practicality.
Reported restricted document access, hindering transparency and equal treatment.
Contradiction regarding e-submission functionality despite 'E-Procurement' characteristic.
Lack of any sustainability, social, or innovation criteria.
Potential for data inconsistencies across different tender information fields.

Rekomendacje

1. Immediately rectify the estimated value to reflect the actual market price for vaccines to ensure fairness and attract qualified bidders.
2. Ensure full and unrestricted access to all tender documents for all potential bidders to uphold transparency and legal compliance.
3. Clarify the e-submission process and ensure full functionality of the e-procurement system.

Podgląd oceny AI

Zarejestruj się, aby zobaczyć pełne wymagania i analizę

Pełna analiza oceny jakości
Szczegółowy rozkład ocen cząstkowych
Mocne strony i obawy – informacje
Rekomendacje strategiczne

Karta kredytowa nie jest wymagana • Konfiguracja w 2 minuty